Literature DB >> 14805135

Activity of plasma labile factor in disease.

M STEFANINI.   

Abstract

Keywords:  BLOOD COAGULATION

Mesh:

Substances:

Year:  1951        PMID: 14805135     DOI: 10.1016/s0140-6736(51)91115-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  THE LABORATORY CONTROL OF THROMBOLYTIC THERAPY.

Authors:  C HAWKEY; M HOWELL
Journal:  J Clin Pathol       Date:  1964-05       Impact factor: 3.411

2.  Idiopathic hyperlipemia. A case report in a nine-year-old Negro girl with an associated deficiency in labile factor and prothrombin.

Authors:  S HARA; G E ACKAOUY; E P CRUMP
Journal:  J Natl Med Assoc       Date:  1962-09       Impact factor: 1.798

3.  A study of the haemorrhagic diathesis in leukaemia and allied diseases.

Authors:  J W THOMAS; R C HASSELBACK; W H PERRY
Journal:  Can Med Assoc J       Date:  1960-09-17       Impact factor: 8.262

4.  Hypoprothrombinaemia in the newborn.

Authors:  A S DOUGLAS; P DAVIES
Journal:  Arch Dis Child       Date:  1955-12       Impact factor: 3.791

5.  The laboratory detection of heterozygotes.

Authors:  D Y HSIA
Journal:  Am J Hum Genet       Date:  1957-06       Impact factor: 11.025

6.  Vascular haemophilia in a woman.

Authors:  J W THOMAS; L BLACK; W H PERRY
Journal:  Can Med Assoc J       Date:  1957-09-01       Impact factor: 8.262

7.  Methods for the investigation of the coagulation mechanism in small children.

Authors:  D J ASHLEY
Journal:  J Clin Pathol       Date:  1958-09       Impact factor: 3.411

8.  A modification for routine laboratory use of Stefanini's method of estimating factor V activity in human oxalated plasma.

Authors:  P WOLF
Journal:  J Clin Pathol       Date:  1953-02       Impact factor: 3.411

9.  Hepatic and cardiac necrosis in a patient with prostatic carcinoma given 6-aminocaproic acid.

Authors:  F NOUR-ELDIN; T F DRAISEY
Journal:  J Clin Pathol       Date:  1963-01       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.